MYLAN-MIRTAZAPINE
MYLAN-MIRTAZAPINE
Approved
DIN Number
02256118
Drug Class
Human
Market Date
Aug 17, 2004
Company
HC
Mylan Pharmaceuticals ULC
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02256118
AIG Number0143928002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N06AX11 MIRTAZAPINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:16.04.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
MIRTAZAPINEActive
Strength: 30 MG
Monograph: MIRTAZAPINE